The Canary Foundation Announces Its Fourth Annual Early Detection...( validation translation approvaland diss...),Health

This year's Symposium attendees and speakers will feature world-renowned scientists, academic researchers and clinicians, as well as Canary Foundation's commercial and foundational partners. Session panels include ovarian cancer screening, biomarker discovery, molecular imaging and updates on Canary's investments towards early detection of ovarian, lung, prostate, and pancreatic cancer. Highlights include:

-- Dr. John Niederhuber, director of the National Cancer Institute (NCI),

will deliver the keynote address and speak on early detection

investment at the NCI. Niederhuber oversees the nation's public

investments and policy decisions in all cancer research, including

early detection.

-- Dr. Leland Hartwell, Nobel Laureate and director of Fred Hutchinson

Cancer Research Center, will provide an overview of the global

investment in early detection.

-- Dr. Ian Jacobs, Director of University College of London (UCL)

Comprehensive Biomedical Research Centre and of UCL's Institute for

Women's Health, will discuss lessons learned from the UK Collaborative

Trial of Ovarian Cancer Screening. The study began in 2000 and is

expected to take 10 years to complete. The study has involved over

200,000 women from 12 collaborating centers in the UK.

"The Early Detection Symposium is a place to share ideas, trends, progress and achievements in early cancer detection," said Don Listwin, founder and chairman of Canary Foundation. "There's a lot of work ahead of us, but through events like this we hope to foster further collaboration with partners and research institutions, which is crucial to reaching the end goal of delivering effective early detection diagnostic tools."

With 100 percent of donations going into early detection
'/>"/>